Latest publications
-
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
Sivakumar S. et al, (2025), Nature Communications, 16
-
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis
Schoenpflug LA. et al, (2025), The Journal of Pathology, 265, 184 - 197
-
Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.
Hassan MZ. et al, (2025), The Lancet regional health. Southeast Asia, 33
-
A core outcome set for maternal and neonatal health research and surveillance of emerging and ongoing epidemic threats (MNH-EPI-COS): a modified Delphi-based international consensus
Pingray V. et al, (2025), eClinicalMedicine, 80
-
A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity
Sadler HL. et al, (2025), Journal of Virology
COI Affiliated Publications (First author/ Corresponding author)
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire
Swanson PA. et al, (2021), Science Translational Medicine
DUB esterase activity further decodes ubiquitin’s enigma
Kessler BM., (2021), Proceedings of the National Academy of Sciences, 118, e2026389118 - e2026389118
COI Affiliated Publications (non-first author/ corresponding author)
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Stuart ASV. et al, (2022), Lancet (London, England), 399, 36 - 49
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation
Asciak R. et al, (2021), Frontiers in Oncology, 11